Document Detail


Isoprostanes in amniotic fluid: a predictive marker for fetal growth restriction in pregnancy.
MedLine Citation:
PMID:  15890628     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Isoprostanes are markers of free radical-catalyzed lipid peroxidation. Evidence suggests that oxidative stress occurs in pregnancies with fetal growth restriction (FGR). The aim of this study was to analyze F2-isoprostanes in amniotic fluid of FGR pregnancies. We tested the hypothesis that F2-isoprostanes are reliable markers to distinguish FGR pregnancies from normal ones and appropriate-for-gestational-age (AGA) from small-for-gestational-age (SGA) newborns. F2-isoprostanes levels were measured by colorimetric enzyme immunoassay in the amniotic fluid of 77 pregnancies with normal fetal growth (group I) and 37 with FGR (group II). Fetal biometry and Doppler measurements were obtained using an ATL HDI 3000 ultrasound system. Isoprostanes were higher in group II than group I. The ROC curve distinguished group I from group II, showing 100% sensitivity and 88.3% specificity at a cutoff of 94 pg/ml. There were no statistical differences in isoprostanes levels between AGA and SGA newborns in group II. The area under the ROC curve drawn to distinguish AGA and SGA newborns showed a sensitivity of 100% and a specificity of 72.3% at a cutoff of 94 pg/ml. The relative risk index indicated a 8.05 times higher risk of birth weight below the 3rd percentiles in group II than in group I. High isoprostanes concentrations can be detected in the amniotic fluid of FGR pregnancies and the assay of isoprostanes in amniotic fluid is a reliable assessment of fetal oxidative stress. Common use of this predictive marker in obstetrics will improve the ability of clinicians to identify those fetuses who will be born SGA or with a birth weight below the 25th percentile.
Authors:
Mariangela Longini; Serafina Perrone; Antonio Kenanidis; Piero Vezzosi; Barbara Marzocchi; Felice Petraglia; Giovanni Centini; Giuseppe Buonocore
Related Documents :
8399018 - The coelomic cavity: an important site of materno-fetal nutrient exchange in the first ...
7590618 - The concentration of hepatocyte growth factor (hgf) in human amniotic fluid at second t...
11562938 - Smith-lemli-opitz (rhs) syndrome: holoprosencephaly and homozygous ivs8-1g-->c genotype.
15350248 - Amniotic fluid volume responses to amnio-infusion of amniotic fluid versus lactated rin...
24173848 - Abdominoplasty: some ideas to improve results.
3081478 - Regulation of breathing movements in fetal sheep by prostaglandin e2.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Free radical biology & medicine     Volume:  38     ISSN:  0891-5849     ISO Abbreviation:  Free Radic. Biol. Med.     Publication Date:  2005 Jun 
Date Detail:
Created Date:  2005-05-13     Completed Date:  2005-10-06     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8709159     Medline TA:  Free Radic Biol Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1537-41     Citation Subset:  IM    
Affiliation:
Department of Pediatrics, Obstetrics and Reproductive Medicine, University of Siena, Policlinico Le Scotte, V.le Bracci 36, 53100 Siena, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
Amniotic Fluid / metabolism*
Biometry
Birth Weight
F2-Isoprostanes / metabolism*
Female
Fetal Growth Retardation / diagnosis*,  metabolism
Gestational Age
Humans
Infant, Newborn
Infant, Small for Gestational Age
Isoprostanes / metabolism*
Oxidative Stress
Pregnancy
ROC Curve
Risk
Sensitivity and Specificity
Ultrasonography, Doppler
Chemical
Reg. No./Substance:
0/F2-Isoprostanes; 0/Isoprostanes

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Glutathione conjugates of 4-hydroxy-2(E)-nonenal as biomarkers of hepatic oxidative stress-induced l...
Next Document:  National Institutes of Health grant awards for pain, nausea, and dyspnea research: an assessment of ...